Cevimeline Hydrochloride
Cevimeline Hydrochloride is a muscarinic agonist with parasympathomimetic activities that is used for the symptomatic treatment of dry mouth in patients with Sjögren’s Syndrome.
Systematic name
(2R)-5'-methyl-4-azaspiro[bicyclo[2.2.2]octane-2,2'-[1,4]oxathiolane] Hydrochloride
Brand name(s)
Evoxac
Therapeutic category
Cholinergic
Available formulations
Solid